Czechia vs Ireland: Reported rate of new cervical cancer cases
Czechia
9.27 per 100,000 women
in 2017
Ireland
9.63 per 100,000 women
in 2017
Czechia rank
18th
Ireland rank
17th
Reported rate of new cervical cancer cases over time
- Czechia
- Ireland
How they compare
Ireland currently reports 9.63 per 100,000 women against 9.27 per 100,000 women in Czechia, a difference of 0.36 per 100,000 women.
The two have swapped places 1 time across 24 shared years of data; in 1994 it was Czechia ahead.
Czechia ranks 18th and Ireland ranks 17th of 46 countries.
Czechia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Czechia | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 15.76 per 100,000 women | 8.41 per 100,000 women | 7.35 per 100,000 women | Czechia |
| 2000s | 13.91 per 100,000 women | 9.38 per 100,000 women | 4.53 per 100,000 women | Czechia |
| 2010s | 10.99 per 100,000 women | 9.98 per 100,000 women | 1.01 per 100,000 women | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Czechia or Ireland?
- Ireland, at 9.63 per 100,000 women against 9.27 per 100,000 women in Czechia as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Czechia and Ireland?
- 0.36 per 100,000 women, with Ireland ahead.
- How many years of comparable data are there for Czechia and Ireland?
- 24 years are reported by both, from 1994 to 2017.
- How do Czechia and Ireland rank globally for reported rate of new cervical cancer cases?
- Czechia ranks 18th and Ireland ranks 17th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.